X4 PHARMACEUTICALS INC (XFORXXXX)
Institutional ownership reported to the SEC as of Q2 2026, across 30 quarters.
1
Reporting holders
$15.1M
Reported value
0.0%
Held as options
-1
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| NEA Management Company, LLC | $15.1M | 3,233,743 | 0.95% | 16q | HELD |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 1 | $15.1M | 3,233,743 | 0 | 0 | 0 | 0.0% |
| Q1 2026 | 2 | $14.3M | 3,467,782 | 0 | 0 | 1 | 0.0% |
| Q4 2025 | 3 | $14.0M | 3,507,120 | 1 | 1 | 0 | 0.0% |
| Q3 2025 | 2 | $8.6M | 2,507,092 | 0 | 2 | 0 | 0.0% |
| Q2 2025 | 2 | $1.2M | 653,289 | 0 | 0 | 2 | 0.0% |
| Q1 2025 | 86 | $23.4M | 98,200,427 | 12 | 24 | 20 | 0.5% |
| Q4 2024 | 84 | $72.4M | 98,113,165 | 12 | 19 | 19 | 0.5% |
| Q3 2024 | 91 | $67.0M | 99,847,863 | 9 | 30 | 18 | 0.3% |
| Q2 2024 | 93 | $60.7M | 104,301,962 | 14 | 31 | 18 | 0.3% |
| Q1 2024 | 92 | $147.0M | 105,272,862 | 15 | 20 | 23 | 0.5% |
| Q4 2023 | 83 | $86.0M | 102,315,434 | 10 | 28 | 17 | 0.2% |
| Q3 2023 | 84 | $122.0M | 111,679,476 | 6 | 25 | 24 | 0.2% |
| Q2 2023 | 92 | $229.7M | 112,662,163 | 45 | 26 | 10 | 4.8% |
| Q1 2023 | 49 | $40.7M | 46,406,262 | 11 | 14 | 7 | 0.4% |
| Q4 2022 | 41 | $42.6M | 42,561,364 | 6 | 12 | 11 | 0.8% |
| Q3 2022 | 57 | $74.2M | 43,261,758 | 15 | 17 | 4 | 0.3% |
| Q2 2022 | 45 | $16.7M | 17,206,178 | 3 | 11 | 9 | 0.3% |
| Q1 2022 | 55 | $30.9M | 17,495,680 | 10 | 12 | 16 | 0.8% |
| Q4 2021 | 51 | $41.3M | 17,655,214 | 13 | 13 | 11 | 2.1% |
| Q3 2021 | 50 | $86.2M | 16,206,423 | 6 | 7 | 22 | 0.5% |
| Q2 2021 | 60 | $111.6M | 17,156,081 | 18 | 9 | 17 | 0.1% |
| Q1 2021 | 60 | $139.0M | 16,163,185 | 12 | 18 | 14 | 0.0% |
| Q4 2020 | 53 | $67.4M | 10,477,888 | 6 | 21 | 13 | 0.0% |
| Q3 2020 | 51 | $69.3M | 10,231,697 | 3 | 15 | 18 | 0.0% |
| Q2 2020 | 56 | $107.8M | 11,554,257 | 16 | 17 | 12 | 1.3% |
| Q1 2020 | 50 | $119.2M | 11,766,798 | 7 | 17 | 16 | 1.3% |
| Q4 2019 | 53 | $121.7M | 11,228,604 | 9 | 24 | 7 | 1.3% |
| Q3 2019 | 50 | $99.0M | 7,742,057 | 9 | 23 | 6 | 0.6% |
| Q2 2019 | 44 | $115.0M | 7,617,987 | 19 | 20 | 1 | 0.7% |
| Q1 2019 | 29 | $31.1M | 1,788,795 | 29 | 0 | 0 | 0.0% |